Exploring Biginelli-based scaffolds as A2B adenosine receptor antagonists: Unveiling novel structure-activity relationship trends, lead compounds, and potent colorectal anticancer agents.
Prieto-Díaz R, Fojo-Carballo H, Majellaro M, Tandarić T, Azuaje J, Brea J, Loza MI, Barbazán J, Salort G, Chotalia M, Rodríguez-Pampín I, Mallo-Abreu A, Rita Paleo M, García-Mera X, Ciruela F, Gutiérrez-de-Terán H, Sotelo E.
Prieto-Díaz R, et al. Among authors: ciruela f.
Biomed Pharmacother. 2024 Apr;173:116345. doi: 10.1016/j.biopha.2024.116345. Epub 2024 Mar 5.
Biomed Pharmacother. 2024.
PMID: 38442670
Free article.